Summary for 5XEJ
| Entry DOI | 10.2210/pdb5xej/pdb |
| Descriptor | Macrophage migration inhibitory factor, SULFATE ION, (2~{R})-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic acid, ... (4 entities in total) |
| Functional Keywords | isomerase-inhibitor complex, isomerase/inhibitor |
| Biological source | Homo sapiens (Human) |
| Total number of polymer chains | 3 |
| Total formula weight | 37903.86 |
| Authors | Takimoto-Kamimura, M.,Fukushima, K. (deposition date: 2017-04-05, release date: 2018-07-25, Last modification date: 2025-03-12) |
| Primary citation | Fukushima, K.,Furuya, M.,Kamimura, T.,Takimoto-Kamimura, M. Structure of macrophage migration inhibitory factor in complex with methotrexate. Acta Crystallogr D Struct Biol, 77:293-299, 2021 Cited by PubMed Abstract: Methotrexate (MTX) is an anticancer and anti-rheumatoid arthritis drug that is considered to block nucleotide synthesis and the cell cycle mainly by inhibiting the activity of dihydrofolate reductase (DHFR). Using affinity-matrix technology and X-ray analysis, the present study shows that MTX also interacts with macrophage migration inhibitory factor (MIF). Fragment molecular-orbital calculations quantified the interaction between MTX and MIF based on the structure of the complex and revealed the amino acids that are effective in the interaction of MTX and MIF. It should be possible to design new small-molecule compounds that have strong inhibitory activity towards both MIF and DHFR by structure-based drug discovery. PubMed: 33645533DOI: 10.1107/S2059798321000474 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report
